Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRQR | AMGN | GILD | CELG | ILMN |
| Company | Proqr Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.01 | 272.14 | 67.09 | 108.01 | 120.82 |
| High | 2.12 | 274.48 | 67.68 | 108.59 | 125.70 |
| Low | 1.99 | 271.05 | 67.00 | 107.27 | 120.82 |
| Last | 2.02 | 273.54 | 67.03 | 108.24 | 124.46 |
| Change | +0.02 | +1.63 | +0.08 | +0.11 | +4.21 |
| % Change | +1.00% | +0.60% | +0.12% | +0.10% | +3.50% |
| Volume | 178,900 | 2,493,200 | 5,239,300 | 191,230,496 | 1,303,000 |
| 20-Day Average Volume | 153,155 | 2,216,500 | 6,335,280 | 16,188,930 | 1,509,115 |
| Previous Close | 2.00 | 271.91 | 66.95 | 108.13 | 120.25 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.15 | 271.99 | 69.34 | 108.17 | 127.06 |
| 20-Day Raw Stochastic | 30.88% | 46.12% | 14.18% | 63.25% | 35.87% |
| 20-Day Relative Strength | 45.94% | 48.69% | 32.82% | 64.69% | 45.12% |
| Weighted Alpha | -0.56 | +11.45 | -20.86 | +46.30 | -36.18 |
| Today's Opinion | 40% Buy | 40% Sell | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 40% Buy | 40% Sell | 100% Sell | 100% Buy | 72% Sell |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Sell | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.00% since 04/16/24 | +2.97% since 04/16/24 | -0.42% since 04/16/24 | -1.97% since 11/13/19 | +5.75% since 04/16/24 |
| Low | 1.81 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 115.73 on 04/18/24 |
| High | 2.12 on 04/23/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 110.53 on 11/14/19 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | -15.13% since 03/22/24 | -0.95% since 03/22/24 | -7.68% since 03/22/24 | +5.14% since 10/18/19 | -9.31% since 03/22/24 |
| Low | 1.81 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 2.49 on 03/26/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | +0.50% since 01/23/24 | -11.74% since 01/23/24 | -15.66% since 01/23/24 | +13.63% since 08/20/19 | -11.57% since 01/23/24 |
| Low | 1.81 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 2.70 on 03/15/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +64.23% since 10/23/23 | +0.18% since 10/23/23 | -13.58% since 10/23/23 | +14.14% since 05/20/19 | +4.18% since 10/23/23 |
| Low | 1.11 on 10/27/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 3.29 on 01/17/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 162,710 | 145,845,984 | 83,357,904 | 77,035,920 | 19,150,414 |
| Shares Outstanding, K | 81,355 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 7,050,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -30,430,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 3,540,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -5,920,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 0.21 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 03/13/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/21/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 9.93 | 10.99 | 134.98 |